Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors
Karin Schreiber(University of Chicago), Hans Schreiber(University of Chicago), Ronald E. Cannon(National Institutes of Health), Dezheng Huo(University of Chicago Medical Center), Gabriele Beck‐Engeser(University of California, San Francisco), Lieping Chen(Yale Cancer Center), Theodore Karrison(University of Chicago), W. Martin Kast(University of Southern California), Raymond W. Tennant(National Institutes of Health), Stephen C. Meredith(University of Illinois Chicago), Thomas Krausz(University of Chicago), Heather Jensen(University of Chicago)
Cited by 45
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k